Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

NCT00646126 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Plasmodium Falciparum
Asymptomatic Parataemia
Sub Patent Parasitaemia

Interventions

DRUG: Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS)
DRUG: placebo tablet similar to active drug in shape and size

Sponsor

Tropical Medicine Research Institute

Collaborators

[object Object]
[object Object]